Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS)

Diabetologia

Volumn 51, Issue 3, 2008, Pages 493-501

  Soedamah Muthu, S S ^a,b   Chaturvedi, N ^c   Pickup, J C ^d   Fuller, J H ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

Author keywords

CHD; Complications; Coronary heart disease; Fibrinogen; Macrovascular; Microvascular; Sialic acid; Type 1 diabetes

Indexed keywords

FIBRINOGEN; SIALIC ACID;

ADULT; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MULTIVARIATE ANALYSIS; NEUROPATHY; PRIORITY JOURNAL; RETINOPATHY; RISK; SEX DIFFERENCE; UNIVARIATE ANALYSIS;

EID: 39049110094     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0905-8     Document Type: Article

References (42)

1. Laing SP, Swerdlow AJ, Slater SD et al (2003) Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46:760-765
2. Soedamah-Muthu SS, Fuller JH, Mulnier HE et al (2006) High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care 29:798-804
3. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL (1991) Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 265:627-631
4. Saito I, Folsom AR, Brancati FL et al (2000) Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med 133:81-91
5. Jager A, van Hinsbergh VW, Kostense PJ et al (2000) Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes 49:485-491
6. Jager A, van Hinsbergh VW, Kostense PJ et al (1999) von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol 19:3071-3078
7. Hoogeveen EK, Kostense PJ, Jakobs C et al (2000) Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study. Circulation 101:1506-1511
8. Pickup JC, Mattock MB (2003) Activation of the innate immune system as a predictor of cardiovascular mortality in type 2 diabetes mellitus. Diabet Med 20:723-726
9. Lindberg G, Rastam L, Gullberg B, Eklund GA (1992) Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: multivariate analysis including 54,385 men and women during 20.5 years follow-up. Int J Epidemiol 21:253-257
10. Pickup JC, Mattock MB, Crook MA et al (1995) Serum sialic acid concentration and coronary heart disease in NIDDM. Diabetes Care 18:1100-1103
11. Kannel WB, D'Agostino RB, Wilson PW, Belanger AJ, Gagnon DR (1990) Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J 120:672-676
12. Ganda OP, Arkin CF (1992) Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes. Diabetes Care 15:1245-1250
13. Powrie JK, Watts GF, Crook MA et al (1996) Serum sialic acid and the long-term complications of insulin-dependent diabetes mellitus. Diabet Med 13:238-242
14. Crook MA, Tutt P, Pickup JC (1993) Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy. Diabetes Care 16:57-60
15. Chen J, Gall MA, Yokoyama H et al (1996) Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy. Diabetes Care 19:130-134
16. Crook MA, Earle K, Morocutti A et al (1994) Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria. Diabetes Care 17:305-310
17. Yokoyama H, Jensen JS, Jensen T, Deckert T (1995) Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy. J Intern Med 237:519-523
18. Crook MA, Pickup JC, Lumb PJ et al (2001) Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study. Diabetes Care 24:316-322
19. EURODIAB IDDM Complications Study group (1994) Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37:278-285
20. Chaturvedi N, Sjoelie AK, Porta M et al (2001) Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes: The EURODIAB PCS. Diabetes Care 24:284-289
21. Chaturvedi N, Bandinelli S, Mangili R et al (2001) Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold. Kidney Int 60:219-227
22. Koivisto VA, Stevens LK, Mattock M et al (1996) Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care 19:689-697
23. Kearney EM, Mount JN, Watts GF, Slavin BM, Kind PR (1987) Simple immunoturbidimetric method for determining urinary albumin at low concentrations using Cobas-Bio centrifugal analyser. J Clin Pathol 40:465-468
24. Bucolo G, David H (1973) Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19:476-482
25. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW (1983) Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29:1075-1080
26. Warnick GR, Albers JJ (1978) A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 19:65-76
27. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
28. John WG, Gray MR, Bates DL, Beacham JL (1993) Enzyme immunoassay - a new technique for estimating hemoglobin A1c. Clin Chem 39:663-666
29. Ford I, Malik RA, Newrick PG et al (1992) Relationships between haemostatic factors and capillary morphology in human diabetic neuropathy. Thromb Haemost 68:628-633
30. Crook M (1993) The determination of plasma or serum sialic acid. Clin Biochem 26:31-38
31. Greaves M, Malia RG, Goodfellow K et al (1997) Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study. Diabetologia 40:698-705
32. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK (1995) Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study. Diabetologia 38:437-444
33. The Consensus Committee of the AAS and the AAN (1996) Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology 46:1470
34. Tesfaye S, Chaturvedi N, Eaton SE et al (2005) Vascular risk factors and diabetic neuropathy. N Engl J Med 352:341-350
35. Prineas RJ, Crow RS, Blackburn H (1982) The Minnesota code manual of electrocardiographic findings. John Wright-PSG, Boston
36. Knuiman MW, Watts GF, Divitini ML (2004) Is sialic acid an independent risk factor for cardiovascular disease? A 17-year follow-up study in Busselton, Western Australia. Ann Epidemiol 14:627-632
37. Yokoyama H, Jensen JS, Myrup B et al (1996) Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. A 10-year follow-up study. Diabetes Care 19:435-440
38. Danesh J, Lewington S, Thompson SG et al (2005) Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 294:1799-1809
39. Danesh J, Collins R, Appleby P, Peto R (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279:1477-1482
40. Ernst E, Resch KL (1993) Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 118:956-963
41. Maresca G, Di Blasio A, Marchioli R, Di Minno G (1999) Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler Thromb Vasc Biol 19:1368-1377
42. Folsom AR, Wu KK, Rasmussen M et al (2000) Determinants of population changes in fibrinogen and factor VII over 6 years: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 20:601-606